BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 35655023)

  • 1. Fate of selected pharmaceuticals in hospital and municipal wastewater effluent: occurrence, removal, and environmental risk assessment.
    Ulvi A; Aydın S; Aydın ME
    Environ Sci Pollut Res Int; 2022 Oct; 29(50):75609-75625. PubMed ID: 35655023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing hospital impact on pharmaceutical levels in a rural 'source-to-sink' water system.
    Niemi L; Taggart M; Boyd K; Zhang Z; Gaffney PPJ; Pfleger S; Gibb S
    Sci Total Environ; 2020 Oct; 737():139618. PubMed ID: 32534267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotics in hospital effluents: occurrence, contribution to urban wastewater, removal in a wastewater treatment plant, and environmental risk assessment.
    Aydin S; Aydin ME; Ulvi A; Kilic H
    Environ Sci Pollut Res Int; 2019 Jan; 26(1):544-558. PubMed ID: 30406596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of selected pharmaceuticals in wastewater treatment plants of Tuscany: An effect-based approach to evaluate the potential environmental impact.
    Palli L; Spina F; Varese GC; Vincenzi M; Aragno M; Arcangeli G; Mucci N; Santianni D; Caffaz S; Gori R
    Int J Hyg Environ Health; 2019 May; 222(4):717-725. PubMed ID: 31101503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring the release of anti-inflammatory and analgesic pharmaceuticals in the receiving environment.
    Aydin S; Aydin ME; Ulvi A
    Environ Sci Pollut Res Int; 2019 Dec; 26(36):36887-36902. PubMed ID: 31745804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of 83 pharmaceuticals in WWTP influent and effluent samples by UHPLC-MS/MS: Hourly variation.
    Paíga P; Correia M; Fernandes MJ; Silva A; Carvalho M; Vieira J; Jorge S; Silva JG; Freire C; Delerue-Matos C
    Sci Total Environ; 2019 Jan; 648():582-600. PubMed ID: 30121536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seasonal occurrence, removal, mass loading and environmental risk assessment of 55 pharmaceuticals and personal care products in a municipal wastewater treatment plant in Central Greece.
    Papageorgiou M; Kosma C; Lambropoulou D
    Sci Total Environ; 2016 Feb; 543(Pt A):547-569. PubMed ID: 26613513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: identification of ecologically relevant pharmaceuticals.
    Santos LH; Gros M; Rodriguez-Mozaz S; Delerue-Matos C; Pena A; Barceló D; Montenegro MC
    Sci Total Environ; 2013 Sep; 461-462():302-16. PubMed ID: 23732224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection, occurrence and fate of 22 psychiatric pharmaceuticals in psychiatric hospital and municipal wastewater treatment plants in Beijing, China.
    Yuan S; Jiang X; Xia X; Zhang H; Zheng S
    Chemosphere; 2013 Mar; 90(10):2520-5. PubMed ID: 23228908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental exposure of pharmaceuticals and musk fragrances in the Somes River before and after upgrading the municipal wastewater treatment plant Cluj-Napoca, Romania.
    Moldovan Z; Chira R; Alder AC
    Environ Sci Pollut Res Int; 2009 Aug; 16 Suppl 1():S46-54. PubMed ID: 18972147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the ebro river basin (northeast Spain).
    Gros M; Petrović M; Barceló D
    Environ Toxicol Chem; 2007 Aug; 26(8):1553-62. PubMed ID: 17702326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial distribution of pharmaceuticals in conventional wastewater treatment plant with Sludge Treatment Reed Beds technology.
    Kołecka K; Gajewska M; Stepnowski P; Caban M
    Sci Total Environ; 2019 Jan; 647():149-157. PubMed ID: 30077845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment.
    Verlicchi P; Al Aukidy M; Galletti A; Petrovic M; Barceló D
    Sci Total Environ; 2012 Jul; 430():109-18. PubMed ID: 22634557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
    Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
    Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracing pharmaceuticals in a municipal plant for integrated wastewater and organic solid waste treatment.
    Jelic A; Fatone F; Di Fabio S; Petrovic M; Cecchi F; Barcelo D
    Sci Total Environ; 2012 Sep; 433():352-61. PubMed ID: 22819886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of pharmaceuticals in municipal wastewater, in the recipient water, and sedimented particles of northern Lake Päijänne.
    Lindholm-Lehto PC; Ahkola HS; Knuutinen JS; Herve SH
    Environ Sci Pollut Res Int; 2015 Nov; 22(21):17209-23. PubMed ID: 26139400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution, mass load and environmental impact of multiple-class pharmaceuticals in conventional and upgraded municipal wastewater treatment plants in East China.
    Yuan X; Qiang Z; Ben W; Zhu B; Qu J
    Environ Sci Process Impacts; 2015 Mar; 17(3):596-605. PubMed ID: 25614232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of multiclass pharmaceutical active compounds (PhACs) in hospital WWTP influent and effluent samples by UHPLC-Orbitrap MS: Temporal variation, removals and environmental risk assessment.
    Kosma CI; Kapsi MG; Konstas PG; Trantopoulos EP; Boti VI; Konstantinou IK; Albanis TA
    Environ Res; 2020 Dec; 191():110152. PubMed ID: 32877707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consumption-based approach for assessing the contribution of hospitals towards the load of pharmaceutical residues in municipal wastewater.
    Le Corre KS; Ort C; Kateley D; Allen B; Escher BI; Keller J
    Environ Int; 2012 Sep; 45():99-111. PubMed ID: 22580296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The occurrence of illicit and therapeutic pharmaceuticals in wastewater effluent and surface waters in Nebraska.
    Bartelt-Hunt SL; Snow DD; Damon T; Shockley J; Hoagland K
    Environ Pollut; 2009 Mar; 157(3):786-91. PubMed ID: 19110357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.